|
Efficacy and safety of tisagenlecleucel (Tisa-cel) in adult patients (Pts) with relapsed/refractory follicular lymphoma (r/r FL): Primary analysis of the phase 2 Elara trial. |
|
|
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Alimera Sciences; BeiGene; Celgene; Genentech/Roche; Juno Therapeutics; Loxo; Nordic Nanovector; Novartis; Tessa Therapeutics |
Research Funding - Abbvie (Inst); Adaptive Biotechnologies (Inst); Celgene (Inst); DTRM (Inst); Genentech/Roche (Inst); Incyte (Inst); Juno Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst) |
Patents, Royalties, Other Intellectual Property - Patent Combination Therapies of CAR and PD-1 Inhibitors (via University of Pennsylvania with royalties to Novartis) |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen; MSD; Novartis; Roche |
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Janssen; Novartis; Roche (I) |
Speakers' Bureau - Novartis |
Research Funding - Celgene (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst) |
Travel, Accommodations, Expenses - Roche |
|
|
Consulting or Advisory Role - Acerta Pharma/AstraZeneca; Bayer/Vital; Beigene; Celgene/Jazz; Gilead Sciences; Janssen-Cilag; Novartis; Roche |
Speakers' Bureau - Bayer Health; Celgene; Gilead Sciences; Janssen-Cilag; Roche Pharma AG |
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen-Cilag (Inst); Roche Pharma AG (Inst) |
Travel, Accommodations, Expenses - Celgene; Janssen-Cilag; Roche Pharma AG |
|
|
Stock and Other Ownership Interests - Altum Sequencing |
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Janssen; Novartis |
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Janssen; Novartis |
Research Funding - Bristol-Myers Squibb; Roche |
|
|
Consulting or Advisory Role - Nordic Nanovector |
Research Funding - Merck; Nordic Nanovector |
Travel, Accommodations, Expenses - Nordic Nanovector |
|
|
Consulting or Advisory Role - Novartis |
Speakers' Bureau - Novartis |
|
|
Research Funding - Bristol-Myers Squibb; Novartis |
|
|
Honoraria - pfizer; Roche |
Travel, Accommodations, Expenses - Novartis |
|
|
No Relationships to Disclose |
|
|
Honoraria - Celgene; Gilead Sciences; Janssen; Novartis; Roche |
Consulting or Advisory Role - Incyte; Roche |
Research Funding - Amgen; Takeda |
|
|
Honoraria - Bristol-Myers Squibb; Celgene; Dainippon-Sumitomo; Janssen; Kyowa Kirin International; MSD; Mundipharma; Ono Pharmaceutical; Takeda |
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Chugai Pharma; Daiichi Sankyo; Eisai; Janssen; Novartis |
Research Funding - Abbvie; Celgene; Chugai Pharma; Daiichi Sankyo; Eisai; Janssen; Kyowa Kirin International; Novartis; Novartis; Ono Pharmaceutical; Takeda |
|
|
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Janssen; Novartis |
Research Funding - Astellas Pharma |
|
|
Honoraria - Kite, a Gilead company; Novartis; Roche |
Consulting or Advisory Role - Kite, a Gilead Company; Miltenyi Biotec (Inst); Novartis; Takeda (Inst) |
Research Funding - Kite, a Gilead company (Inst) |
Travel, Accommodations, Expenses - Celgene; Kite, a Gilead Company; Novartis; Roche |
|
|
Employment - Genentech (I) |
Stock and Other Ownership Interests - Roche/Genentech (I) |
Consulting or Advisory Role - Atara Biotherapeutics; Epizyme; Gilead Sciences; Incyte; Karyopharm Therapeutics; Kite, a Gilead company; TG therapeutics |
Research Funding - Amgen; Celgene; GlaxoSmithKline; Juno Therapeutics; Merck; Novartis |
Travel, Accommodations, Expenses - Gilead Sciences; Kite, a Gilead company |
|
|
|
Consulting or Advisory Role - Bayer; BeiGene; Bristol-Myers Squibb/Celgene; Karyopharm Therapeutics; Kite, a Gilead company; Novartis; Takeda; Verastem |
Speakers' Bureau - Bayer; Kite, a Gilead company |
Research Funding - Bristol-Myers Squibb/Celgene; Calibr; Kite, a Gilead company; MorphoSys; Novartis |
|
|
Employment - Novartis Pharmaceuticals UK Ltd. |
|
|
Employment - Novartis Pharmaceuticals UK Ltd. |
|
|
|
|
|
Consulting or Advisory Role - Bayer; Celgene; Novartis; Roche/Genentech; TG Therapeutics; Verastem |
Research Funding - Abbvie; BeiGene; Celgene; Gilead Sciences; Novartis; Roche; TG Therapeutics |
|
|
Honoraria - Abbvie; Bayer; Celgene; Gilead Sciences; Incyte; Janssen; Novartis; Roche |
|
Travel, Accommodations, Expenses - Janssen-Cilag; Kite/Gilead; Novartis; Roche |